Editorial: Genetics of barrett's: The bigger, the better

American Journal of Gastroenterology

Volumn 107, Issue 9, 2012, Pages 1342-1345

  El Omar, Emad M ^a   Jankowski, Janusz ^b,c,d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18;

BARRETT ESOPHAGUS; CANCER SUSCEPTIBILITY; ESOPHAGEAL ADENOCARCINOMA; GENETIC PREDISPOSITION; HUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; ADENOCARCINOMA; ESOPHAGUS TUMOR; FEMALE; GENETICS; MALE; NOTE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-18; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84866137167     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.144     Document Type: Review

References (17)

1. Jankowski J, Barr H, Wang K et al. Diagnosis and management of Barrett's oesophagus. Brit Med J 2010;341:c4551.
2. Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the West. Gastroenterology 2002;122:588-90.
3. Jankowski J, Odze R. Bio markers in gastroenterology; between hypeand hope comes histopathology. Am J Gastroenterol 2009; 104: 1093-6.
4. Robertson EV, Jankowski JA. Genetics of gastroesophageal cancer: paradigms, paradoxes and prognostic utility. Am J Gastroenterol 2008;103:443-9.
5. Babar M, Ryan AW, Anderson LA et al. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's Esophagus and Esophageal Adenocarcinoma. Am J Gastroenterol 2012;107:1331-1341 (this issue).
6. Merlo LM, Shah NA, Li X et al. A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res (Phila) 2010;11: 1388-97.
7. van de Winkel A, Menke V, Capello A et al. Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma. BMC Gastroenterol 2011;11:108.
8. McElholm AR, McKnight AJ, Patterson CC et al. A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence. Gastroenterology 2010; 139: 204. e3-12. e3.
9. Ferguson HR, Wild CP, Anderson LA et al. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett ' s esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett ' s adenocarcinoma relationship case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:736-9.
10. Ferguson HR, Wild CP, Anderson LA et al. Cancer Epidemiol Biomarkers Prev 2008;17:736-9.
11. Menke V, van Zoest KP, Moons LM et al. Nco I TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma. Scand J Gastroenterol 2012;6:-386.
12. Menke V, Pot RG, Moons LM et al. Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma. J Hum Genet 2012;57:26-32.
13. Orlof M, Peterson C, He X et al. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocar-cinoma. JAMA 2011;306:410-9.
14. Hinch AG, Tandon A, Patterson N et al. The landscape of recombination in African Americans. Nature 2011;476:170-5.
15. Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20.
16. Kahrilas PJ. The role of hiatus hernia in GERD. Yale J Biol Med 1999;72:101-11.
17. Su Z, Gay L, Palles C et al. Common variants at the MHC locus and at chromosome 16q24. 1 predispose to Barrett's esophagus. Nat Genet (in press).